卓昇有限公司–最專業科學研究供應商
The SW 780 line was established in 1974 by A. Leibovitz from a grade I transitional cell carcinoma. The patient had preoperative chemotherapy (Thiotepa). The cells have a reported plating efficiency of 41%.
ABC-TC1190
SW 780
Human
Tumor Cell Lines
1 vial
Dry Ice
Liquid Nitrogen
Accegen Biotechnology